ADRB2 and cancer: In vitro experiments show that the immunosuppressive effects of MDSCs treated with ISO on the proliferation of CD8+ and CD4+ T cells are stronger than those of the control MDSCs.138,139 Additionally, β-AR activation inhibits type I and II interferon production, which attenuates cell-mediated immune activities against cancer cells as well as oncogenic viruses.140